Found 18 matching trials
National Project on Vaccines, COVID-19 and Frail Patients
N/AThis is a multicentre observational study with the aim of evaluating the an...
Location
IRCCS Istituto Tumori Giovanni Paolo II
Brainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence
NAIntroduction Pierre Robin Sequence, PRS, incidence is about one hundred bir...
Location
Hopital Femme Mère Enfant
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
PHASE1This Phase 1b, open-label, single-center, prospective trial will be assessi...
Location
Royal London Hospital-Clinical Research Facility-11D (11th Floor) Whitechapel, London, E1 1FR,
Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine
PHASE4The yellow fever vaccine is a live, attenuated virus that results in a robu...
Location
The Hope Clinic of Emory Vaccine Center
Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients
NAThe purpose of this study is to analyze Fitbit data to predict infection af...
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
National Registry of Rare Kidney Diseases
N/AThe goal of this National Registry is to is to collect information from pat...
Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases
PHASE2This phase II trial studies how well chemotherapy and/or metastasectomy wor...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Trial of Pegasys® in Patients With Chronic Hepatitis C
PHASE4The purpose of this study is to investigate the efficacy and safety of Pega...
Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease
PHASE1The main objectives of the study are to determine peak plasma drug concentr...
Location
Children's Hospital of Philadelphia
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
PHASE1This is a Phase 1b, open-label, multicenter, safety, tolerability and effic...
Location
University of Arizona Cancer Center